{"member_organisations": "", "identification_number": "255298920864-73", "fields_of_interest": "Public Health", "head_office_address": "Wielsekade 64", "full_time_equivalent_fte": "0,5", "person_with_legal_responsibility": "Willem Scholten", "industry_forums": "", "grants": "", "country_code": "nl", "inter_groups": "", "eu_initiatives": "Policies of the EU Hortizontal Drugs Group with regards to EU position taken in the UN Commission on Narcotic Drugs en WHO, in particular the ECDD; Commenting on drug control policies by publishing and presenting at conferences, e.g. the EU focused annual SIP conference; \nResearching and promoting access to controlled medicines globally; Expert Member of a guidelines group of the CoE Pompidou Group developing guidelines on access to pharmacological treatment of opioid dependence.", "level_of_interest": "European, global", "organisation_name": "Willem Scholten Consultancy", "belgium_office_post_code": "", "number_of_persons_involved": "1", "person_in_charge_of_eu_relations": "Willem Scholten", "section": "I - Professional consultancies/law firms/self-employed consultants", "lon": "4.9249132", "source": "", "subsection": "Self-employed consultants", "belgium_office_phone": "", "overall_budget_turnover_as_a_range": "0-99999", "belgium_office_address": "", "persons_accredited_for_access_to_european_parliament_premises": "", "registration_date": "01/03/2016", "estimate_of_costs_absolute_amount": "", "website_address": "", "commission_expert_groups_and_other_similar_entities_european_commission": "NA", "head_office_post_box": "", "head_office_city": "Lopik", "membership": "Koninklijke Nederlandse Maatschappij ter Bevordering van de Pharmacie (KNMP) \nInternational Association for Hospice and Palliative Care (IAHPC)", "head_office_post_code": "3411AD", "position": "owner", "financial_year_start_date": "01/01/2017", "head_office_country": "Netherlands", "number_of_ep_accredited_persons": "", "relevant_communication": "Former Project Manager, EU FP7 Project Access to Controlled Medicines in Europe (ATOME): analysing drug control policies and legislation in 12 Eastern European countries and drafting policy recommendations for these countries. \nRegular speaker at the Societal Impact of Pain conference, held biannually, usually at the EP with sponsorship of MEPs.  \nSee Google Scholar Citations for publications.", "financial_year_end_date": "01/12/2017", "lat": "51.9746788", "estimate_of_costs_as_a_range": "10000-24999", "overall_budget_turnover_absolute_amount": "", "legal_status": "one-man business", "procurement": "", "customers": "Gr\u00fcnenthal", "belgium_office_post_box": "", "goals__remit": "Consultant - Medicines and Controlled Substances, i.e. independent consultant in the area of improving access to controlled medicines and (psychoactive) substance control policies.", "belgium_office_city": "", "head_office_phone": "(+31)348769029"}